Federal Circuit paves way for Eli Lilly testosterone generics

23-11-2017

Federal Circuit paves way for Eli Lilly testosterone generics

makaule / iStockphoto.com

Eli Lilly experienced a setback yesterday at the US Court of Appeals for the Federal Circuit when it affirmed that a patent owned by the company is invalid.


Eli Lilly, Actavis, Lupin, Watson, Amneal, US Court of Appeals for the Federal Circuit, patent, patent infringement, ANDA, generics

LSIPR